Physician

General Surgery

Roberto Gedaly is an expert in the field of General Surgery. He received awards:"Fellow (FACS)". Roberto Gedaly is a published doctor and has 44 publications published. The lastest was: 'Laparoscopic jejunostomy with an 18-mm trocar.' He is registered with Medicare and accepts Medicare payments.

Publications

---

• Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
• Donor Positive Blood Culture is associated with Delayed Graft Function in Kidney Transplant Recipients: A Propensity Score Analysis of the UNOS Database.
• A prospective analysis of factors associated with decreased physical activity in patients with cirrhosis undergoing transplant evaluation.
• Role of Transplantation in the Treatment of Benign Solid Tumors of the Liver: A Review of the United Network of Organ Sharing Data Set.
• Risk Factors for 30-day Readmissions after Hepatectomy: Analysis of 2444 Patients from the ACS-NSQIP Database.
• Direct intranodal lymphangiography for recurrent chylous ascites following liver/kidney transplantation.
• Synergistic Inhibition of HCC and Liver Cancer Stem Cell Proliferation by Targeting RAS/RAF/MAPK and WNT/β-Catenin Pathways.
• Molecular Therapies in Hepatocellular Carcinoma: What Can We Target?
• PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation.
• Peri-operative challenges and long-term outcomes in liver transplantation for polycystic liver disease.
• Thrombectomy and cavo-cavostomy for inferior vena cava thrombosis and torsion after piggyback liver transplantation.
• Targeting the Wnt/β-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma Cell Lines with FH535.
• The Role of Bridging Therapy in Hepatocellular Carcinoma.
• Predictors of surgical site infection after liver resection: a multicentre analysis using National Surgical Quality Improvement Program data.
• Liver Transplantation for the Treatment of Liver Metastases From Neuroendocrine Tumors: An Analysis of the UNOS Database.
• PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.
• Predicting dry weight in patients with ascites and liver cirrhosis using computed tomography imaging.
• Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.
• Transjugular intrahepatic portosystemic shunt to keep vein open.
• Cyclosporine promotes epstein-barr virus-infected human B-cell transformation assayed by three correlated assay methods.
• Obesity, diabetes, and smoking are important determinants of resource utilization in liver resection: a multicenter analysis of 1029 patients.
• Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease.
• An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
• Seatbelt injury resulting in functional loss of a transplanted kidney.
• Vaginal varices with massive hemorrhage in a patient with nonalcoholic steatohepatitis and portal hypertension: Successful treatment with liver transplantation.
• Successful open pulmonary embolectomy for acute massive pulmonary embolism in a recent kidney transplant recipient.
• Cyclosporin A-induced lipid and protein oxidation in human B-cells and in Epstein-Barr virus-infected B-cells is prevented by antioxidants.
• Prevalent immunosuppressive strategies in liver transplantation for hepatitis C: results of a multi-center international survey.
• Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells.
• Surgical treatment of a rare primary renal carcinoid tumor with liver metastasis.
• The use of Dacron graft for cavo-cavostomy in orthotopic liver transplantation.
• Successful management of eviscerated renal allograft with preservation of function.
• Importance of local infection in hepatic artery pseudoaneurysms.
• A pharmacoeconomic analysis of liver transplant charges.
• Duodenal drainage during pancreas transplantation.
• Treatment of liver metastases from a solid pseudopapillary tumor of the pancreas.
• Liver transplantation for the treatment of nonresectable metastatic duodenal paraganglioma.
• Are liver grafts from hepatitis B surface antigen negative/anti-hepatitis B core antibody positive donors suitable for transplantation?
• Use of percutaneous liver biopsies in marginal liver donors.
• Distal splenorenal shunt: role, indications, and utility in the era of liver transplantation.
• Cavernous hemangioma of the liver: anatomic resection vs. enucleation.
• Laparoscopic jejunostomy with an 18-mm trocar.
• Liver transplantation for the treatment of neuroendocrine liver metastases.

Schools

---

• Universidad Central De VenezuelaLuis Razetti Escuela De Medicine Luis Razetti

Doctors Specialties

---

• General Surgery
• Transplant Surgery

Accepted Insurances

---

Awards

---

• Fellow (FACS)

Hospital

---

• University of Kentucky Albert B. Chandler Hospital

Drug Facts

---

NPI NUMBER		1962469361
NPPES Provider LastName		GEDALY
NPPES Provider FirstName		ROBERTO
NPPES Provider ZIPCode		405360001
NPPES Provider State		KY
Specialty Description		General Surgery
Total Claim Count		331.0
Distinct Opioid Count		1.0
Opioid Claim Count		11.0
Percent Opioid Claims		3.32

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1962469361
Last Name Of The Provider	GEDALY
First Name Of The Provider	ROBERTO
View All

Similar Doctors

---

	Dr. Carol D. Spears, MD
	Dr. Andrew M. Moore II, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles S. Mooney, MD
	Dr. John S. Roth, MD This Doctor is OpenDoctor Recommended.
	Dr. Erin C. Maynard, MD This Doctor is OpenDoctor Recommended.
	Dr. William B. Greiser, MD This Doctor is OpenDoctor Recommended.
	Dr. John M. Hance, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog